Biolidics Overview

  • Founded
  • 2009
Founded
  • Status
  • Public
  • Employees
  • 26
Employees
  • Stock Symbol
  • 8YY
Stock Symbol
  • Share Price
  • $0.11
  • (As of Monday Closing)

Biolidics General Information

Description

Biolidics Ltd is engaged in research, experimental development, marketing, and distribution of biotechnology, life and medical science and electronics related industrial design services and investment holding. Its segments include Cancer; Infectious diseases; Laboratory services; and Corporate segment. It derives major revenue from The infectious diseases segment that involves the identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship network and direct customers in the infectious diseases field. Its operations are spread across Singapore, Japan, China, Europe, United States, Hong Kong, Philippines, Indonesia, and Others.

Contact Information

Website
www.biolidics.com
Formerly Known As
Clearbridge BioMedics
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Stock Exchange
SES
Primary Office
  • 37 Jalan Pemimpin
  • Number 02-07
  • Mapex, 577177
  • Singapore

Biolidics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biolidics Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.11 $0.11 $0.09 - $0.26 $28.1M 265M 1.04M -$0.02

Biolidics Financials Summary

In Thousands,
USD 		TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 51,156 56,205 37,434 50,579
Revenue 1,816 6,456 1,054 939
EBITDA (4,572) (2,600) (3,135) (3,916)
Net Income (5,604) (3,371) (3,525) (4,632)
Total Assets 11,202 14,175 7,136 10,386
Total Debt 3,549 3,987 398 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Biolidics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biolidics‘s full profile, request access.

Request a free trial

Biolidics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Biolidics Ltd is engaged in research, experimental development, marketing, and distribution of biotechnology, life and m
Biotechnology
Mapex, Singapore
26 As of 2018
000.00
000000000 000.00

00000000

agna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex e
0000000000000
San Francisco, CA
000 As of 0000
00000
000000000 00000

00000 00

sequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
000000000000000
Ahmedabad, India
00000 As of 0000
000.00
000000 - 000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biolidics Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Fluidigm Formerly VC-backed San Francisco, CA 000 00000 000000000 00000
00000 000000000000 Private Equity-Backed Ahmedabad, India 00000 000.00 000000 - 000 000.00
000000 Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
000000 000 0000000 Formerly VC-backed Lowell, MA 0 000.00 000000000 000.00
To view Biolidics’s complete competitors history, request access »

Biolidics Patents

  • 18

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Biolidics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2016405636-B2 Systems and methods for enriching target cells in a sample Active 04-May-2016 000000000000 0
AU-2016405636-A1 Systems and methods for enriching target cells in a sample Granted 04-May-2016 000000000000
EP-3455337-A4 Systems and methods for enriching target cells in a sample Pending 04-May-2016 000000000000 0
EP-3455337-A1 Systems and methods for enriching target cells in a sample Pending 04-May-2016 000000000000
JP-6924210-B2 Systems and methods for enriching target cells in a sample Active 04-May-2016 B01L3/502761
To view Biolidics’s complete patent history, request access »

Biolidics Executive Team (13)

Name Title Board Seat Contact Info
Song Yih Chief Executive Officer & Executive Director
Wang Qing-Yin Ph.D Chief Operating Officer
Tan Chee Financial Controller
Man Leong Chief Commercial Officer
Chwee Lim Ph.D Co-Founder & Advisor
You’re viewing 5 of 13 executive team members. Get the full list »

Biolidics Board Members (7)

Name Representing Role Since
Beng Kwan Chia Biolidics Board Member 000 0000
Jeremy Yee Self Co-Chief Executive Officer & Non-Executive Non-Independent Chairman 000 0000
Johnson Chen Self Board Member & Founder 000 0000
Tony Qian Biolidics Board Member 000 0000
You’re viewing 4 of 7 board members. Get the full list »

Biolidics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biolidics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biolidics‘s full profile, request access.

Request a free trial